Insider Cluster (5 insiders) ·Filed Jul 2, 2026

KYMR

Kymera Therapeutics, Inc.
BEARISH
Impact 5/10
Horizonweeks Processed3mo ago
Insider cluster: 3 insiders, $13.2M total
Actionable Insight ▼ Bearish

The CEO and CFO both exercised options and sold large blocks of shares within the same week, a pattern that often signals a desire to lock in gains after a significant stock run-up. While the dollar amount is modest relative to market cap, the concentration of C-suite selling is a cautionary signal. Monitor for any upcoming catalyst (data readout, partnership, or offering) that might have prompted the timing. The stock's 93% analyst bullish consensus and strong recent performance suggest the selling may be liquidity-driven, but the cluster warrants a watchful stance.

DirectionBearish
Confidencemedium
Horizonweeks
Latest settled — T+60d ⚠ clustered
KYMR ▲ +2.03% at T+60d
SHORT call ✗ call lost -2.03% · α vs SPY +0.98% · entry $113.51 → $115.81
Next anchor: T+1d due 3mo ago
Entry anchored
Jul 1, 03:59 PM ET
via exchange tick
T+1d
—
call — · α —
—
due 3mo ago
T+5d
+4.84%
call -4.84% · α -3.91%
$119.00
settled 3mo ago
T+20d
-5.73%
call +5.73% · α +5.31%
$107.01
settled 2mo ago
T+60d
+2.03%
call -2.03% · α +0.98%
$115.81
settled 7d ago

Price Chart

Loading chart...

Executive Summary

Three Kymera insiders — including CEO Nello Mainolfi, CFO Bruce Jacobs, and a director — sold a combined ~$13.2M in open-market shares over a 7-day window ending July 1, 2026. CEO Mainolfi alone sold ~$9.2M after exercising options, while CFO Jacobs sold ~$9.9M. The cluster represents ~0.14% of Kymera's $9.4B market cap, falling in the modest-to-notable proportionality band. While the dollar value is not overwhelming relative to market cap, the concentration of C-suite selling — particularly the CEO and CFO both selling within days of each other — warrants attention, especially given the stock's strong recent performance and the company's 93% analyst bullish consensus.

Key Financial Metrics

Direction
selling
Total Value
$19.4M
Insiders
5

Key Facts

  • CEO Nello Mainolfi sold ~$9.2M in open-market shares on July 1, 2026, after exercising options.
  • CFO Bruce Jacobs sold ~$9.9M in open-market shares on June 30, 2026, after exercising options.
  • Director Bruce Booth sold ~$281K in open-market shares on June 29, 2026.
  • Total insider selling in the cluster: ~$19.4M (combining the 7-day window and the prior week's data).
  • The cluster represents ~0.21% of Kymera's $9.4B market cap, falling in the modest-to-notable proportionality band.
  • CEO and CFO both exercised options and immediately sold a large portion of the resulting shares — a pattern consistent with tax- and liquidity-driven selling, but the concentration and timing are notable.
  • The stock has rallied significantly (prior reports show +11% and +16% T+5 moves on neutral/long calls), and insiders are selling into strength.

Financial Impact

Total insider selling of ~$19.4M over a 7-day window, representing ~0.21% of Kymera's $9.4B market cap.

insider ownershipfloat

Risk Factors

  • CEO and CFO both sold large blocks after option exercises — potential signal of peak valuation sentiment.
  • Total insider selling of ~$19.4M in a 7-day window is notable for a $9.4B market cap company.
  • Stock has rallied significantly in recent months; insiders may be taking profits near a perceived top.
  • No insider buying to offset the selling — one-sided selling cluster.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (30 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-KYMR-1783060609015
30 reports for KYMR
Performance horizon
64% Hit rate 7 of 11 directional calls best @ T+60▲ +60.99%Jun 8, 2026
Filters
Rows
Reports for KYMR — sortable, filterable
TypeNow
Aug 5, 2026
8w ago
8-K
BULLISH ★ 6/10
$105.48 $118.63▲ +12.47%▲ +13.07%$107.39 (+1.81%)
Jul 8, 2026
12w ago
Insider Cluster
BEARISH ★ 5/10
$114.16 $105.48▲ +7.60%▲ +10.88%$107.39 (+5.93%)
Jul 2, 2026
13w ago
Insider Cluster
BEARISH ★ 6/10
$113.51 $107.01▲ +5.73%▲ +5.31%$107.39 (+5.39%)
Jul 2, 2026
13w ago
Insider Cluster
BEARISH ★ 5/10
$113.51 $107.01▲ +5.73%▲ +5.31%$107.39 (+5.39%)
Jun 30, 2026
13w ago
144
BEARISH ★ 4/10
$114.20 $105.25▲ +7.84%▲ +5.65%$107.39 (+5.96%)
Jun 29, 2026
13w ago
144
NEUTRAL ★ 4/10
$114.67 $110.05▼ −4.03%▼ −3.00%$107.39 (−6.35%)
Jun 26, 2026
13w ago
Insider Cluster
BEARISH ★ 6/10
$109.32 $110.57▼ −1.14%▼ −1.42%$107.39 (+1.77%)
Jun 26, 2026
13w ago
144
BEARISH ★ 6/10
$109.32 $110.57▼ −1.14%▼ −1.42%$107.39 (+1.77%)
Jun 26, 2026
13w ago
144
BEARISH ★ 6/10
$109.32 $110.57▼ −1.14%▼ −1.42%$107.39 (+1.77%)
Jun 24, 2026
14w ago
144
NEUTRAL ★ 2/10
$116.46 $110.38▼ −5.22%▼ −5.75%$107.39 (−7.79%)
Showing 10 of 30

US Market Status

Market Closed — Opens Mon (65h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 3, 2026